Selected References:
- AAP Committee on Drugs. 2001. The transfer of drugs and other chemicals into human milk. Pediatrics 108:776-789.
- Acar S, et al. 2019. Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis. Reprod Toxicol, 85:65-74.
- Berkovitch M, et al. 1994. Safety of the new quinolones in pregnancy. Obstet Gynecol, 84(4):535-538.
- Boissiere-O’Neill T, et al. 2025. Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population-Based Registry Study. BJOG.
- Bomford JAL, et al. 1993. Ciprofloxacin use during pregnancy. Drugs, 45(S3): 461-462.
- Cavusoglu I, et al. 2016. Evaluation of teratogenic effects of ciprofloxacin in pregnant women exposed due to urinary tract infections (abstract). Reprod Toxicol, 60:178.
- Cover DL, Mueller BA. 1990. Ciprofloxacin penetration into human breast milk: a case report. DICP, 24:703-704.
- Damkier P, et al. 2019. In utero exposure to antibiotics and risk of congenital malformations: a population-based study. Am J Obstet Gynecol; 221(6):648.e1-648.e15.
- Gardner D, et al. 1992. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. Clin Pharm, 11:352-354.
- Kabeya CM, et al. 1995. Ciprofloxacin for multiresistant enteric fever in pregnancy. The Lancet, 346:307-308.
- Leung D, et al. 1995. Treatment of typhoid in pregnancy. The Lancet, 346:648.
- Loebstein R, et al. 1998. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother, 42(6):1336-1339.
- Meaney-Delman D, et al. 2013 Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol, 122(4):885-900.
- Muanda FT, et al. 2017. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population-based cohort study. Br J Clin Pharmacol; 83:2557–2571.
- Nahum G, et al. 2006. Antibiotic use in pregnancy and lactation. Obstet Gynecol, 107(5):1120-1138.
- Noergaard M, et al. 2022. Ciprofloxacin exposure and adverse pregnancy outcomes: A Danish nationwide cohort study. BJOG, 129(9):1503-1511.
- Padberg S, et al. 2014. Observational cohort study of pregnancy outcomes after first-trimester exposure to fluoroquinolones. Antimicrob Agents Chemother, 58(8):4392-4398.
- Schaefer C, et al. 1996. Pregnancy outcome after prenatal quinolone exposure: evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol, 69:83-89.
- Schluter G. 1989. Ciprofloxacin: toxicologic evaluation of additional safety data. The Am J Med, 87(5A):S37-S39.
- Van Wattum JJ, et al. 2019. Antibiotics and lactation: An overview of relative infant doses and a systematic assessment of clinical studies. Basic Clin Pharmacol Toxicol, 124(1):5-17.
- Xiang DC, et al. 2024. Pregnancy-related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS). Heliyon. 10(18):e37547.
- Xiong W, et al. 2024. Association between maternal antibiotic exposure and emotional and behavioural problems in children at four years of age: A biomonitoring-based prospective study. Ecotoxicol Environ Saf. 284:116949.
- Yefet E, et al. 2018. The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis.
